Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diagnostic Firm Biofield Looks To Broaden Scope in China and India

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Looking to penetrate deeper into the Asian market, diagnostic equipment distributor Biofield, owned by Hong Kong-based MacKay Holdings, has acquired new cancer diagnostic products which it plans to market in China and India. Last week, the company announced it had acquired worldwide distribution rights for various cancer diagnostic products from ValiRx, a UK-based biotechnology company that focuses on cancer products
Advertisement

Related Content

MacKay Group Chairman James MacKay On Pursuing A “Starbucks” Model For Diagnostics In China: An Interview With PharmAsia News
MacKay Group Chairman James MacKay On Pursuing A “Starbucks” Model For Diagnostics In China: An Interview With PharmAsia News
Advertisement
UsernamePublicRestriction

Register

SC070759

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel